Products
| CATALOG NO | PRODUCT NAME | CAS | PURITY | STRUCTURE |
|---|---|---|---|---|
| 16122736 | Lirametostat ( CPI-1205 ) | 1621862-70-1 | ≧98.0% | _1621862-70-1.png) |
| CPI-1205 is a potent, selective, and cofactor-competitive inhibitor of wild type and | ||||
| 41788 | CB-6644 | 2316817-88-4 | 96.33% |  |
| CB-6644 acts as a noncompetitive ATPase inhibitor. Additionally, it can inhibit RUVBL | ||||
| 210507 | LP-261 | 915412-67-8 | ≧98.0% |  |
| LP-261 is a novel tubulin targeting anticancer agent that binds at the colchicine sit | ||||
| 21255 | 2,4-dimethoxy-6-methylnicotinonitrile | 1450662-05-1 | ≧95.0% |  |
| 2,4-dimethoxy-6-methylnicotinonitrile, is a key intermediate ofLirametostat ( CPI-120 | ||||
| 21257 | Difelikefalin | 1024828-77-0 | ≧98.0% |  |
| Difelikefalin, also known CR-845; MR-13A-9; MR-13A9, is a novel and potent kappa opio | ||||
| 18435 | Ritlecitinib ( PF-06651600 ) | 1792180-81-4 | ≧98.0% | _1792180-81-4.png) |
| Ritlecitinib ( PF-06651600 ) is a potent and selective JAK3 inhibitor. PF-06651600, a | ||||
| 2091204 | 5-hydroxy-2,4-dimethylpyrimidine | 412003-95-3 | ≧98.0% |  |
| 2,4-dimethylpyrimidin-5-ol is a key intermidiate ofLemborexant. Kg scale may be provi | ||||
| 201221 | Razuprotafib sodium | 1809275-69-1 | ≧98.0% |  |
| Razuprotafib, also known as AKB-9778, is a small molecule inhibitor of vascular endot | ||||
| 21252 | SM-102 | 2089251-47-6 | ≧98.0% |  |
| SM-102 is an ionizable amino lipid that has been used in combination with other lipid | ||||
| 16122809 | Elacestrant | 722533-56-4 | ≧98.0% |  |
| Elacestrant, also known as RAD1901, is an orally available, selective estrogen recept | ||||
| 20103002 | Senaparib | 1401682-78-7 | ≧98.0% |  |
| Senaparib (IMP4297) is a novel agent targeting PARP (poly-ADP ribose polymerase) with | ||||
| 20103004 | 2,6-difluoro-3,5-dimethoxybenzeneamine | 651734-54-2 | ≧98.0% |  |
| 2,6-difluoro-3,5-dimethoxybenzeneamine is a key intermeidate ofPemigatinib.1Kg~10Kg s | ||||